Cencora
Price data unavailable
Track COR in your trading journalAbout Cencora
Cencora (Nasdaq/NYSE: COR) is a Health Care Distributors company operating within the Health Care sector of the US equity market.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
The company reports trailing twelve-month revenue of $78.36B and net income of $1.64B.
Key metrics include a return on equity of 48.3%.
Use FINOTAUR to track COR's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $78.36B |
| Net Income (TTM) | $1.64B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 48.31% |
| Debt-to-Equity | — |
| Dividend per Share | — |
Recent News
- GlobeNewswire Inc.·May 18
COR Investors Have Opportunity to Join Cencora, Inc. Fraud Investigation with the Schall Law Firm
- Benzinga·Feb 4
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
- GlobeNewswire Inc.·Jan 23
Comparator Drug Sourcing Market to Reach USD 2.72 Billion by 2033, Driven by Rising Global Clinical Trials and Outsourcing Trends – SNS Insider
Want real-time analysis on COR?
Track it free in your trading journal. Log trades, tag setups, and review your edge.